Onco-cardiology: Drug-drug interactions of antineoplastic and cardiovascular drugs

Crit Rev Oncol Hematol. 2020 Jan:145:102822. doi: 10.1016/j.critrevonc.2019.102822. Epub 2019 Nov 13.

Abstract

Cardiovascular diseases (CVD) and cancer are still the leading causes of death. There are many common etiologic factors, especially smoking and obesity. Therefore, it is not uncommon for CVD and cancer to coexist. Drug-drug interactions (DDIs) inevitably occur in this group of patients, where polypharmacy is increasing due to older age and multiple comorbidities. However, multidisciplinary studies, especially close collaboration of medical oncologists and cardiologists, who deals with the diagnosis and treatment of these diseases, awareness and preventive approaches to DDIs may reduce serious morbidity and mortality. In this review, information about the common treatments used in cardiology and oncology and possible DDIs are discussed.

Keywords: Cancer; Cardiovascular disease; Drug-drug interaction.

Publication types

  • Review

MeSH terms

  • Aged
  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / pharmacology
  • Cardiology
  • Cardiovascular Agents* / adverse effects
  • Cardiovascular Agents* / pharmacology
  • Cardiovascular Diseases* / drug therapy
  • Drug Interactions*
  • Humans
  • Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents
  • Cardiovascular Agents